Exploring insulin analogue safety and effectiveness in a Maghrebian cohort with type 2 diabetes: results from the A1chieve study
M Belhadj, A Dahaoui, H Jamoussi… - Diabetes Research and …, 2013 - Elsevier
Aim To evaluate the safety and effectiveness of insulin analogues in patients with type 2
diabetes (T2D) from Morocco, Algeria and Tunisia that formed the Maghrebian cohort of the
24-week, non-interventional A 1 chieve study. Methods Patients starting biphasic insulin
aspart, insulin detemir and insulin aspart, alone or in combination, were included. The
primary outcome was the incidence of serious adverse drug reactions (SADRs), including
major hypoglycaemic events. Secondary outcomes included hypoglycaemia, glycated …
diabetes (T2D) from Morocco, Algeria and Tunisia that formed the Maghrebian cohort of the
24-week, non-interventional A 1 chieve study. Methods Patients starting biphasic insulin
aspart, insulin detemir and insulin aspart, alone or in combination, were included. The
primary outcome was the incidence of serious adverse drug reactions (SADRs), including
major hypoglycaemic events. Secondary outcomes included hypoglycaemia, glycated …
